Malabsorption syndrome after gastroenteritis in children, optimization of therapy

Authors

  • O.H. Shadrin SI «Institute of Pediatrics, Obstetrics and Gynecology named after academician O.M. Lukyanova of the NAMS of Ukraine», Kyiv, Ukraine https://orcid.org/0000-0002-5901-7013
  • R.V. Marushko SI «Institute of Pediatrics, Obstetrics and Gynecology named after academician O.M. Lukyanova of the NAMS of Ukraine», Kyiv, Ukraine https://orcid.org/0000-0001-7855-1679
  • T.L. Marushko SI «Institute of Pediatrics, Obstetrics and Gynecology named after academician O.M. Lukyanova of the NAMS of Ukraine», Kyiv, Ukraine https://orcid.org/0000-0001-5139-882X
  • A.A. Kovalchuk SI «Institute of Pediatrics, Obstetrics and Gynecology named after academician O.M. Lukyanova of the NAMS of Ukraine», Kyiv, Ukraine https://orcid.org/0009-0000-3561-2865
  • R.V. Mostovenko National Children’s Specialized Hospital «OKHMATDYT», Kyiv, Ukraine

DOI:

https://doi.org/10.15574/SP.2023.134.37

Keywords:

children, malabsorption syndrome, bacterial overgrowth syndrome, enterosorbents, highly dispersed silicon dioxide

Abstract

The period of convalescence after gastroenteritis in children in modern circumstances is often complicated by the development of post-infectious malabsorption syndrome, in the pathogenesis of which the development of bacterial overgrowth syndrome (BOS) is important. At present, the issue of treatment of BOS in children has not been finally resolved. The use of modern enterosorbents can be considered a good alternative to antibacterial therapy of BOS.

Purpose - to evaluate the effectiveness of the inclusion of highly dispersed silicon dioxide in the complex therapy of malabsorption syndrome after gastroenteritis in children.

Materials and methods. 30 children aged from 3 to 12 years with malabsorption syndrome after gastroenteritis during the last 6 months were under observation. Patients on the background of standard treatment were prescribed highly dispersed silicon dioxide for 3-5 days. In dynamics, subjective complaints of patients and/or their parents were assessed, clinical symptoms and results of coprological and bacteriological examination of feces were evaluated.

Results. While including highly dispersed silicon dioxide into the treatment, in the vast majority of patients (according to individual indicators, 75-85%), a rapid normalization of the frequency and consistency of stools, a decrease in the frequency and severity of flatulence, improvement of digestion and assimilation of nutrients according to the indicators of a coprological study, which had a positive effect on the general condition, were noted. The results of the bacteriological examination of feces in dynamics showed a significant decrease in the frequency of detection and the number of opportunistic bacteria, fungal flora and tendency to increase the number of representatives of the indigenous microflora.

Conclusions. The results of the work make it possible to recommend the inclusion of enterosorption with the usage of highly dispersed silicon dioxide in the complex of restorative therapy in children with malabsorption syndrome after gastroenteritis.

The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee of the institution mentioned in the work. The informed consent of the children’s parents was obtained for the conducting the studies.

No conflict of interests was declared by the authors.

References

Aguilar F, Charrondiere UR. Dusemund B, Galtier P, Gilbert J, Gott DM et al. (2009). Calcium silicate and silicon dioxide/silicic acid gel added for nutritional purposes to food supplements. EFSA J. 1132: 1-24. https://doi.org/10.2903/j.efsa.2009.1132

Das JK, Bhutta ZA. (2016). Global challenges in acute diarrhea. Curr. Opin. Gastroenterol. 32 (1): 18-23. https://doi.org/10.1097/MOG.0000000000000236; PMid:26574867

GBD Diarrhoeal Diseases Collaborators. (2017). Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Infect. Dis. 17 (9): 909-948. https://doi.org/10.1016/S1473-3099(17)30276-1; PMid:28579426

Guerrant RG, DeBoer MD, Moore SM, Scharf RJ, Lima AAM. (2013). The impoverished gut - a triple burden of diarrhoea, stunting and chronic disease. Nat. Rev. Gastroenterol. Hepatol. 10 (4): 220-229. https://doi.org/10.1038/nrgastro.2012.239; PMid:23229327 PMCid:PMC3617052

Howell CA, Markaryan E, Allgar V, Kemppinen A et al. (2019). Enterosgel for the treatment of adults with acute diarrhoea in a primary care setting: a randomised controlled trial. BMJ Open Gastroenterol. 6 (1): e000287. https://doi.org/10.1136/bmjgast-2019-000287; PMid:31139427 PMCid:PMC6505981

Iddrisu I, Monteagudo-Mera A, Poveda C, Pyle S, Shahzad M, Andrews S, Walton GE. (2021). Malnutrition and Gut Microbiota in Children. Nutrients. 13 (8): 2727. https://doi.org/10.3390/nu13082727; PMid:34444887 PMCid:PMC8401185

Malyi VP, Asoian IM, Tkachuk Yu V, Nartov PV, Maslova V S. (2019). Optimization of detoxification therapy in patients with gastro-intestinal infections. Clinical immunology. Allergology. Infectology. 5 (118): 42-45. URL: https://kiai.com.ua/uploads/issues/2019/5(118)/kiai19_42-45_9b77012e0ab992463a9e031078d601b5.pdf.

Patterson GT, Manthi D, Osuna F, Muia A, Olack B, Mbuchi M et al. (2021). Environmental, Metabolic, and Inflammatory Factors Converge in the Pathogenesis of Moderate Acute Malnutrition in Children: An Observational Cohort Study. Am. J. Trop. Med. Hyg. 104 (5): 1877-1888. https://doi.org/10.4269/ajtmh.20-0963; PMid:33755580 PMCid:PMC8103470

Rodriguz DA, Mac Daragh PR, Monjaraz EM et al. (2019). Small Intestimal Bacterial Overgrawth in Children: A State-Of-the Art Review. Front Pediatr. 7: 363. https://doi.org/10.3389/fped.2019.00363; PMid:31552207 PMCid:PMC6737284

Sieczkowska A, Landowski P, Kamińska B, Lifschitz C. (2016). Small Bowel Bacterial Overgrowth in Children. J. Pediatr. Gastroenterol. Nutr. 62 (2): 196-207. https://doi.org/10.1097/MPG.0000000000000920; PMid:26196206

Silicol. (2023). Manufacturer of healthcare products. Web-ресурс. URL: http://www.silicol.com/.

Squellati R. (2018). Evidence-based practice in the treatment for antibiotic-associated diarrhea in the intensive care unit. Crit. Care Nurs. Clin. North Am. 30 (1): 87-99. https://doi.org/10.1016/j.cnc.2017.10.008; PMid:29413218

Tieroshyn V, Moroz L, Prishliak O et al. (2020). Colloidal Silicon Dioxide in Tablet form (Carbowhite) Efficacy in Patients with Acute Diarrhea: Results of Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study. Sci Rep. 10: 6344. https://doi.org/10.1038/s41598-020-62386-0; PMid:32286322 PMCid:PMC7156649

Troeger C, Colombara DV, Rao PC, Khalil IA, Brown A, Brewer TG e al. (2018). Global disability-adjusted life-year estimates of long-term health burden and undernutrition attributable to diarrhoeal diseases in children younger than 5 years. Lancet Glob Health. 6 (3): e255-e269. https://doi.org/10.1016/S2214-109X(18)30045-7; PMid:29433665

Voronin EP, Chekman IS, Rudenko AV, Nosach LV, Osіnnya LM. (2017). Properties of nanoscale silica as medical sorbent. Integrative Anthropology. 1 (29): 44-48. URL: http://files.odmu.edu.ua/anthropology/2017/01/a171_44.pdf.

Voronin EP, Nosach LV, Pakhlov EM, Gun'ko, IS Chekman VM, Rudenko AV et al. (2016). Creation of stable aqueous dispersions of nanosilica as an enterosorbent. Poverkhnost. 8 (23): 267-283. URL: http://dspace.nbuv.gov.ua/bitstream/handle/123456789/148509/24-Voronin.pdf?sequence=1. https://doi.org/10.15407/Surface.2016.08.267

Younes M, Aggett P, Aguilar F et al. (2018). Scientific Opinion on the re-evaluation of silicon dioxide (E 551) as a food additive. EFSA Journal. 16 (1): 5088, 70. https://doi.org/10.2903/j.efsa.2018.5088; PMid:32625658

Published

2023-10-28

Issue

Section

Original articles